Document is current
Any future updates will be listed below
-
Authors
Lin, Jake
Moradi, Elaheh
Salenius, Karoliina https://orcid.org/0000-0003-1104-0406
Lehtipuro, Suvi
Häkkinen, Tomi
Laiho, Jutta E.
Oikarinen, Sami
Randelin, Sofia
Parikh, Hemang M. https://orcid.org/0000-0002-9076-6709
Krischer, Jeffrey P.
Toppari, Jorma https://orcid.org/0000-0003-2228-334X
Lernmark, Åke https://orcid.org/0000-0003-1735-0499
Petrosino, Joseph F.
Ajami, Nadim J. https://orcid.org/0000-0002-3808-8576
She, Jin-Xiong
Hagopian, William A. https://orcid.org/0000-0003-2979-0475
Rewers, Marian J. https://orcid.org/0000-0003-3829-9207
Lloyd, Richard E.
Rautajoki, Kirsi J. https://orcid.org/0000-0001-6549-7810
Hyöty, Heikki https://orcid.org/0000-0003-0370-4145
Nykter, Matti https://orcid.org/0000-0001-6956-2843
,
- License Information
-
More Information
Article History
Received: 1 February 2023
Accepted: 17 October 2023
First Online: 22 November 2023
Competing interests
: H.H. is a shareholder and chairman of the board of Vactech, and a member of the Scientific Advisory Board of Provention Bio, which develops vaccines against picornaviruses and CVB. The remaining authors declare no competing interests.
